Companion Diagnostics FoundationOne CDx and VITRAKVI Used to Treat Solid Tumors
Source: Pixabay

Companion Diagnostics FoundationOne CDx and VITRAKVI Used to Treat Solid Tumors

In late October, molecular information company Foundation Medicine, Inc. ("Foundation") shared that its diagnostic tool FoundationOne CDx was approved as a companion diagnostic for VITRAKVI (larotrectinib). While FoundationOne CDx will…

Continue Reading Companion Diagnostics FoundationOne CDx and VITRAKVI Used to Treat Solid Tumors
Genomic Testing for Rare Cancers
source: pixabay.com

Genomic Testing for Rare Cancers

According to an article from BioSpace, the TargetCancer Foundation has began enrolling patients in their TRACK study. This study is intended to provide rare cancer patients with individualized treatment options…

Continue Reading Genomic Testing for Rare Cancers